FirstHealth of the Carolinas

Clinical Trial Details

Study Title: SOLSTICE: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Study Type: Interventional
Study Condition: Endometriosis
Investigator: Dr. John Byron
Phone: (910) 692-7928
Research Coordinator: Valerie Palumbo
Phone: (910) 715-2200
Eligibility Criteria: Premenopausal women, ages 18 to 49, with a diagnosis of endometriosis. For additional criteria, call the Research Coordinator or visit the study weblink.
Sponsor Organization: AbbVie
Study Rationale:
Study Purpose: A randomized study evaluating the safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.
Study Link:
FirstHealth @ Facebook.comFirstHealth @ Twitter.comFirstHealth @ Pinterest.comFirstHealth @
Physicians Employees
Working Together, First in Quality, First in Health
Site MapPrivacy PolicyTerms & ConditionsHelp © FirstHealth of the Carolinas, Inc.